Status:
COMPLETED
Letigen® and Cardiovascular Morbidity
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
Nycomed Group, Langebjerg 1, 4000 Roskilde, Denmark
Conditions:
Stroke
Myocardial Infarctions
Eligibility:
All Genders
18-70 years
Brief Summary
Letigen® was a combination drug containing ephedrine, an adrenergic agonist with lipolytic and appetite-inhibiting properties. The drug was used as adjuvant treatment of obesity from 1990 and up to 20...
Eligibility Criteria
Inclusion
- Use of letigen TM within the period Jan 1995 - Dec 2001
- The occurrence of a case-defining event
Exclusion
- A cancer diagnosis other than non-melanoma skin cancer
- Age outside the range 18-70
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
End Date :
August 1 2007
Estimated Enrollment :
300000 Patients enrolled
Trial Details
Trial ID
NCT00692666
Start Date
May 1 2006
End Date
August 1 2007
Last Update
June 6 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.